DK119009B - Analogifremgangsmåde til fremstilling af optisk aktive eller racemiske 5,9-diethyl-2'-hydroxy-2-substituerede-6,7-benzomorphan-forbindelser eller syreadditionssalte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af optisk aktive eller racemiske 5,9-diethyl-2'-hydroxy-2-substituerede-6,7-benzomorphan-forbindelser eller syreadditionssalte deraf.

Info

Publication number
DK119009B
DK119009B DK262167AA DK262167A DK119009B DK 119009 B DK119009 B DK 119009B DK 262167A A DK262167A A DK 262167AA DK 262167 A DK262167 A DK 262167A DK 119009 B DK119009 B DK 119009B
Authority
DK
Denmark
Prior art keywords
racemic
diethyl
hydroxy
substituted
preparation
Prior art date
Application number
DK262167AA
Other languages
Danish (da)
English (en)
Inventor
J Nicholson
F Robinson
P Anderson
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK119009B publication Critical patent/DK119009B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK262167AA 1966-05-20 1967-05-19 Analogifremgangsmåde til fremstilling af optisk aktive eller racemiske 5,9-diethyl-2'-hydroxy-2-substituerede-6,7-benzomorphan-forbindelser eller syreadditionssalte deraf. DK119009B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55155166A 1966-05-20 1966-05-20
US63049367A 1967-04-13 1967-04-13

Publications (1)

Publication Number Publication Date
DK119009B true DK119009B (da) 1970-11-02

Family

ID=27069800

Family Applications (1)

Application Number Title Priority Date Filing Date
DK262167AA DK119009B (da) 1966-05-20 1967-05-19 Analogifremgangsmåde til fremstilling af optisk aktive eller racemiske 5,9-diethyl-2'-hydroxy-2-substituerede-6,7-benzomorphan-forbindelser eller syreadditionssalte deraf.

Country Status (15)

Country Link
US (1) US3514463A (el)
AT (1) AT279636B (el)
BE (1) BE698687A (el)
CH (1) CH517098A (el)
CS (1) CS152282B2 (el)
DE (1) DE1695417A1 (el)
DK (1) DK119009B (el)
ES (2) ES340655A1 (el)
FR (1) FR7149M (el)
GB (2) GB1173224A (el)
GR (1) GR33684B (el)
IL (1) IL27871A (el)
NL (2) NL6706977A (el)
NO (1) NO122790B (el)
SE (1) SE345267B (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700734A (en) * 1969-01-23 1972-10-24 Merck & Co Inc 2{40 -hydroxy-2,3,5-trimethyl-6,7-benzomorphan
IE34235B1 (en) * 1969-06-04 1975-03-19 Acf Chemiefarma Nv 6,7-benzomorphans and their preparation
DE2233088A1 (de) * 1972-06-30 1974-01-17 Schering Ag Benzomorphanderivate
US3891657A (en) * 1972-10-26 1975-06-24 Bristol Myers Co 9Beta-hydroxy-5-methyl-6,7-benzomorphans
US4022789A (en) * 1975-11-20 1977-05-10 Sterling Drug Inc. Dichlorocyclopropylmethyl-benzazocines
BE864950A (fr) * 1976-09-22 1978-09-18 Sterling Drug Inc 2,6-methano-3-benzazocines
US4341904A (en) * 1980-02-19 1982-07-27 Merck & Co., Inc. Derivatives of 2-hydroxy-6,9-methano-11-amino-5,6,7,8,9,10-hexahydro-benzocyclooctene
US4332810A (en) * 1981-01-26 1982-06-01 Merck & Co., Inc. N-(Substituted)-2,5-ethano-8-hydroxy (or methoxy)-1,2,3,4,5,6-hexahydro-3 (or 4)-benzazocine centrally-acting analgesics
US4332807A (en) * 1981-01-26 1982-06-01 Merck & Co., Inc. N-Substituted-benzyl-11-endo-amino-5,6,7,8,9,10-hexahydro-2-hydroxy (or methoxy)-6,9-methanobenzocyclooctene (or nonene) centrally-acting analgesics

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE246157C (el) *
US2259513A (en) * 1939-03-01 1941-10-21 Du Pont Methods of inhibiting polymerization of unsaturated methylene compounds
US2369158A (en) * 1941-10-01 1945-02-13 Research Corp Synthesis of vitamin a
US2388657A (en) * 1943-04-15 1945-11-06 Wingfoot Corp Preparation of acid chlorides
US2713574A (en) * 1951-05-24 1955-07-19 American Cyanamid Co New syntheses of peptides and substituted amides
DE1420015B1 (de) * 1959-10-16 1971-08-26 Boehringer Sohn Ingelheim 2'-Hydroxy-5,9-dimethyl-6,7-benzomorphane
US3372165A (en) * 1960-12-01 1968-03-05 Sterling Drug Inc 1, 2, 3, 4, 5, 6-hexahydro-8-hydroxy-2, 6-methano-3-benzazocine derivatives
GB997637A (en) * 1962-01-31 1965-07-07 Smith Kline French Lab Substituted 2-cyclopropylmethyl-6,7-benzmorphans
US3250678A (en) * 1963-01-16 1966-05-10 Sterling Drug Inc Analgesia producing benzazocines
NL130089C (el) * 1963-11-07

Also Published As

Publication number Publication date
FR7149M (el) 1969-08-04
NO122790B (el) 1971-08-16
CS152282B2 (el) 1973-12-19
GB1173224A (en) 1969-12-03
ES369141A1 (es) 1971-06-01
DE1695417A1 (de) 1970-07-16
CH517098A (de) 1971-12-31
BE698687A (el) 1967-11-20
ES340655A1 (es) 1969-11-01
GB1173221A (en) 1969-12-03
NL6706977A (el) 1967-11-21
SE345267B (el) 1972-05-23
IL27871A (en) 1971-05-26
US3514463A (en) 1970-05-26
NL132139C (el)
GR33684B (el) 1968-01-10
AT279636B (de) 1970-03-10

Similar Documents

Publication Publication Date Title
DK130070B (da) Analogifremgangsmåde til fremstilling af 3,4-dihydroxyphenylalkanolaminer eller syreadditionssalte deraf.
DK120750B (da) Analogifremgangsmåde til fremstilling af azaspiroalkandion-forbindelser eller syreadditionssalte deraf.
DK115473B (da) Fremgangsmåde til fremstilling af 2,3,4,5-tetrahydro-1H-3-benzazepiner eller syreadditionssalte deraf.
DK131029B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-alkylaminopropaner eller syreadditionssalte deraf.
DK129447B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-sek.-alkylaminopropaner eller syreadditionssalte heraf.
DK124404B (da) Fremgangsmåde til fremstilling af 2-arylamino-1,3-diazacycloalkener-(2) eller syreadditionssalte deraf.
DK125021B (da) Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydro-4-phenyl-isoquinolinderivater eller syreadditionssalte deraf eller de tilsvarende optisk aktive forbindelser.
DK136527B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive p-alkoxyfenoxypropanolaminer eller syreadditionssalte deraf.
DK140281B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-cycloalkylaminopropaner eller syreadditionssalte heraf.
DK122133B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive substituerede 3-alkoxythianaphthen-2-carboxamider eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK121512B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive substituerede 5-phenyl-6,7-benzomorphaner eller syreadditionssalte deraf.
DK127599B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 2,4-diaminosubstituerede quinazolin-forbindelser eller syreadditionssalte heraf.
DK124081B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive piperazinderivater eller syreadditionssalte deraf.
DK119009B (da) Analogifremgangsmåde til fremstilling af optisk aktive eller racemiske 5,9-diethyl-2'-hydroxy-2-substituerede-6,7-benzomorphan-forbindelser eller syreadditionssalte deraf.
DK118607B (da) Analogifremgangsmåde til fremstilling af 2-phenylhydrazino-imidazolin-2-forbindelser eller syreadditionssalte deraf.
DK131988B (da) Analogifremgangsmåde til fremstilling af optisk aktive eller racemiske 1-aryloxy-2-hydroxy-3-isopropylamino-propaner eller syreadditionssalte heraf.
DK139582B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive benzocycloheptaisoquinolin-forbindelser eller syreadditionssalte deraf.
DK126594B (da) Analogifremgangsmåde til fremstilling af 3-morpholino-N<6>-cyclohexylcarbonylsydnonimin eller syreadditionssalte deraf.
DK121367B (da) Analogifremgangsmåde til fremstilling af 3,3-difenylallylaminderivater eller syreadditionssalte deraf.
DK135231B (da) Analogifremgangsmåde til fremstilling af basisk substituerede 2,3-cis, trans-diphenylcyclopropanderivater eller syreadditionssalte deraf.
DK115110B (da) Fremgangsmåde til fremstilling af anticholeterolemeisk sktive 25-aza-19-nor-1,3,5(10)-cholestatriener eller syreadditionssalte deraf.
DK123102B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive benzo[b]thiopheneddikesyreforbindelser eller carboxylatsalte deraf.
DK129699B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 9,10-dihydro-9,10-ethano-anthracener eller syreadditionssalte deraf.
DK118657B (da) Analogifremgangsmåde til fremstilling af 3',4',5'-trimethoxy-3-aminoacrylophenoner eller syreadditionssalte deraf.
DK118668B (da) Fremgangsmåde til fremstilling af tetrahydro-1,3,5-thiadiazin-2-thioner eller syreadditionssalte deraf.